Eli Lilly maker of Trump-touted COVID-19 drug in FDA trouble, pauses trial
U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly and Co pharmaceutical plant that is ramping up to manufacture one of two promising COVID-19 drugs touted…